Annual EBITDA:
$36.90M+$555.10M(+107.12%)Summary
- As of today, EBS annual EBITDA is $36.90 million, with the most recent change of +$555.10 million (+107.12%) on December 31, 2024.
- During the last 3 years, EBS annual EBITDA has fallen by -$424.60 million (-92.00%).
- EBS annual EBITDA is now -93.38% below its all-time high of $557.70 million, reached on December 31, 2020.
Performance
EBS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$100.60M+$76.10M(+310.61%)Summary
- As of today, EBS quarterly EBITDA is $100.60 million, with the most recent change of +$76.10 million (+310.61%) on September 30, 2025.
- Over the past year, EBS quarterly EBITDA has increased by +$2.70 million (+2.76%).
- EBS quarterly EBITDA is now -71.28% below its all-time high of $350.30 million, reached on December 31, 2021.
Performance
EBS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$215.80M+$2.70M(+1.27%)Summary
- As of today, EBS TTM EBITDA is $215.80 million, with the most recent change of +$2.70 million (+1.27%) on September 30, 2025.
- Over the past year, EBS TTM EBITDA has increased by +$190.40 million (+749.61%).
- EBS TTM EBITDA is now -67.34% below its all-time high of $660.70 million, reached on March 31, 2021.
Performance
EBS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EBS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +107.1% | +2.8% | +749.6% |
| 3Y3 Years | -92.0% | +904.8% | -38.2% |
| 5Y5 Years | -83.7% | +10.3% | -43.7% |
EBS EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -92.0% | +107.1% | at high | +177.6% | -38.2% | +222.0% |
| 5Y | 5-Year | -93.4% | +107.1% | -71.3% | +177.6% | -67.3% | +222.0% |
| All-Time | All-Time | -93.4% | +107.1% | -71.3% | +177.6% | -67.3% | +222.0% |
EBS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $100.60M(+310.6%) | $215.80M(+1.3%) |
| Jun 2025 | - | $24.50M(-67.2%) | $213.10M(+261.8%) |
| Mar 2025 | - | $74.60M(+363.4%) | $58.90M(+11.3%) |
| Dec 2024 | $36.90M(+107.1%) | $16.10M(-83.6%) | $52.90M(+108.3%) |
| Sep 2024 | - | $97.90M(+175.5%) | $25.40M(+152.8%) |
| Jun 2024 | - | -$129.70M(-289.1%) | -$48.10M(-137.4%) |
| Mar 2024 | - | $68.60M(+701.8%) | $128.70M(+308.3%) |
| Dec 2023 | -$518.20M(-1249.5%) | -$11.40M(-146.7%) | -$61.80M(+7.3%) |
| Sep 2023 | - | $24.40M(-48.2%) | -$66.70M(+35.6%) |
| Jun 2023 | - | $47.10M(+138.6%) | -$103.60M(+41.4%) |
| Mar 2023 | - | -$121.90M(-647.9%) | -$176.90M(-928.5%) |
| Dec 2022 | -$38.40M(-108.3%) | -$16.30M(-30.4%) | -$17.20M(-104.9%) |
| Sep 2022 | - | -$12.50M(+52.3%) | $349.40M(-3.2%) |
| Jun 2022 | - | -$26.20M(-169.3%) | $360.80M(-17.1%) |
| Mar 2022 | - | $37.80M(-89.2%) | $435.30M(-16.7%) |
| Dec 2021 | $461.50M(-17.2%) | $350.30M(>+9900.0%) | $522.70M(+13.4%) |
| Sep 2021 | - | -$1.10M(-102.3%) | $461.10M(-16.7%) |
| Jun 2021 | - | $48.30M(-61.4%) | $553.40M(-16.2%) |
| Mar 2021 | - | $125.20M(-56.6%) | $660.70M(+19.4%) |
| Dec 2020 | $557.70M(+146.2%) | $288.70M(+216.6%) | $553.20M(+44.4%) |
| Sep 2020 | - | $91.20M(-41.4%) | $383.20M(-2.0%) |
| Jun 2020 | - | $155.60M(+779.1%) | $391.20M(+52.2%) |
| Mar 2020 | - | $17.70M(-85.1%) | $257.10M(+7.7%) |
| Dec 2019 | $226.50M(+47.5%) | $118.70M(+19.7%) | $238.80M(+51.5%) |
| Sep 2019 | - | $99.20M(+361.4%) | $157.58M(+70.7%) |
| Jun 2019 | - | $21.50M(+3683.3%) | $92.32M(-38.7%) |
| Mar 2019 | - | -$600.00K(-101.6%) | $150.62M(-2.9%) |
| Dec 2018 | $153.60M(-8.5%) | $37.48M(+10.4%) | $155.10M(-18.3%) |
| Sep 2018 | - | $33.95M(-57.5%) | $189.85M(-11.4%) |
| Jun 2018 | - | $79.80M(+1958.3%) | $214.40M(+39.8%) |
| Mar 2018 | - | $3.88M(-94.6%) | $153.31M(-12.3%) |
| Dec 2017 | $167.80M(+15.7%) | $72.23M(+23.5%) | $174.73M(+15.4%) |
| Sep 2017 | - | $58.49M(+212.6%) | $151.38M(+8.8%) |
| Jun 2017 | - | $18.71M(-26.0%) | $139.08M(+9.3%) |
| Mar 2017 | - | $25.30M(-48.3%) | $127.26M(-3.6%) |
| Dec 2016 | $145.00M(-18.3%) | $48.88M(+5.8%) | $131.96M(-11.2%) |
| Sep 2016 | - | $46.19M(+570.6%) | $148.64M(-9.8%) |
| Jun 2016 | - | $6.89M(-77.0%) | $164.87M(-12.0%) |
| Mar 2016 | - | $30.00M(-54.2%) | $187.39M(+34.6%) |
| Dec 2015 | $177.57M(+42.2%) | $65.56M(+5.0%) | $139.18M(+10.1%) |
| Sep 2015 | - | $62.42M(+112.2%) | $126.40M(+21.5%) |
| Jun 2015 | - | $29.41M(+261.4%) | $104.00M(+14.4%) |
| Mar 2015 | - | -$18.22M(-134.5%) | $90.91M(-3.5%) |
| Dec 2014 | $124.89M | $52.79M(+31.9%) | $94.21M(+34.7%) |
| Sep 2014 | - | $40.02M(+145.2%) | $69.93M(+30.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2014 | - | $16.32M(+209.4%) | $53.51M(-6.6%) |
| Mar 2014 | - | -$14.92M(-152.4%) | $57.28M(-11.9%) |
| Dec 2013 | $61.76M(+42.7%) | $28.50M(+20.8%) | $65.04M(+1.5%) |
| Sep 2013 | - | $23.61M(+17.5%) | $64.08M(+20.8%) |
| Jun 2013 | - | $20.09M(+380.4%) | $53.07M(+20.2%) |
| Mar 2013 | - | -$7.17M(-126.0%) | $44.16M(-13.0%) |
| Dec 2012 | $43.27M(+4.8%) | $27.55M(+118.9%) | $50.76M(-29.4%) |
| Sep 2012 | - | $12.59M(+12.5%) | $71.95M(+13.4%) |
| Jun 2012 | - | $11.19M(+2080.4%) | $63.48M(-17.8%) |
| Mar 2012 | - | -$565.00K(-101.2%) | $77.18M(+65.0%) |
| Dec 2011 | $41.30M(-48.0%) | $48.74M(+1086.0%) | $46.78M(+17.1%) |
| Sep 2011 | - | $4.11M(-83.5%) | $39.96M(-32.4%) |
| Jun 2011 | - | $24.89M(+180.4%) | $59.13M(+16.2%) |
| Mar 2011 | - | -$30.96M(-173.9%) | $50.88M(-41.4%) |
| Dec 2010 | $79.36M(+70.6%) | $41.92M(+80.1%) | $86.86M(+61.2%) |
| Sep 2010 | - | $23.28M(+39.9%) | $53.89M(+93.6%) |
| Jun 2010 | - | $16.64M(+231.4%) | $27.83M(-28.6%) |
| Mar 2010 | - | $5.02M(-43.9%) | $38.96M(-25.7%) |
| Dec 2009 | $46.52M(+25.6%) | $8.95M(+421.7%) | $52.47M(+14.6%) |
| Sep 2009 | - | -$2.78M(-110.0%) | $45.79M(-29.8%) |
| Jun 2009 | - | $27.77M(+49.9%) | $65.19M(+58.4%) |
| Mar 2009 | - | $18.53M(+715.9%) | $41.16M(+18.0%) |
| Dec 2008 | $37.02M(-2.3%) | $2.27M(-86.3%) | $34.89M(-54.7%) |
| Sep 2008 | - | $16.62M(+344.6%) | $77.00M(+16.6%) |
| Jun 2008 | - | $3.74M(-69.5%) | $66.06M(+20.6%) |
| Mar 2008 | - | $12.26M(-72.4%) | $54.80M(+44.6%) |
| Dec 2007 | $37.91M(-12.3%) | $44.38M(+680.3%) | $37.91M(-2.5%) |
| Sep 2007 | - | $5.69M(+175.6%) | $38.88M(-10.4%) |
| Jun 2007 | - | -$7.52M(-62.4%) | $43.39M(-40.4%) |
| Mar 2007 | - | -$4.63M(-110.2%) | $72.86M(-26.7%) |
| Dec 2006 | $43.22M(-16.0%) | $45.35M(+344.7%) | $99.44M(+558.3%) |
| Sep 2006 | - | $10.20M(-53.5%) | $15.11M(-55.4%) |
| Jun 2006 | - | $21.95M(0.0%) | $33.87M(-17.2%) |
| Mar 2006 | - | $21.95M(+156.3%) | $40.89M(-14.6%) |
| Dec 2005 | $51.46M(+247.3%) | -$38.99M(-234.6%) | $47.91M(+28.7%) |
| Sep 2005 | - | $28.97M(0.0%) | $37.23M(+27.8%) |
| Jun 2005 | - | $28.97M(0.0%) | $29.14M(+38.5%) |
| Mar 2005 | - | $28.97M(+158.3%) | $21.05M(+62.5%) |
| Dec 2004 | $14.82M(-73.4%) | -$49.67M(-337.9%) | $12.95M(-79.3%) |
| Sep 2004 | - | $20.87M(0.0%) | $62.62M(+50.0%) |
| Jun 2004 | - | $20.87M(0.0%) | $41.75M(+100.0%) |
| Mar 2004 | - | $20.87M | $20.87M |
| Dec 2003 | $55.77M(+47.7%) | - | - |
| Dec 2002 | $37.77M(-16.6%) | - | - |
| Dec 2001 | $45.31M | - | - |
FAQ
- What is Emergent BioSolutions Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Emergent BioSolutions Inc.?
- What is Emergent BioSolutions Inc. annual EBITDA year-on-year change?
- What is Emergent BioSolutions Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Emergent BioSolutions Inc.?
- What is Emergent BioSolutions Inc. quarterly EBITDA year-on-year change?
- What is Emergent BioSolutions Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Emergent BioSolutions Inc.?
- What is Emergent BioSolutions Inc. TTM EBITDA year-on-year change?
What is Emergent BioSolutions Inc. annual EBITDA?
The current annual EBITDA of EBS is $36.90M
What is the all-time high annual EBITDA for Emergent BioSolutions Inc.?
Emergent BioSolutions Inc. all-time high annual EBITDA is $557.70M
What is Emergent BioSolutions Inc. annual EBITDA year-on-year change?
Over the past year, EBS annual EBITDA has changed by +$555.10M (+107.12%)
What is Emergent BioSolutions Inc. quarterly EBITDA?
The current quarterly EBITDA of EBS is $100.60M
What is the all-time high quarterly EBITDA for Emergent BioSolutions Inc.?
Emergent BioSolutions Inc. all-time high quarterly EBITDA is $350.30M
What is Emergent BioSolutions Inc. quarterly EBITDA year-on-year change?
Over the past year, EBS quarterly EBITDA has changed by +$2.70M (+2.76%)
What is Emergent BioSolutions Inc. TTM EBITDA?
The current TTM EBITDA of EBS is $215.80M
What is the all-time high TTM EBITDA for Emergent BioSolutions Inc.?
Emergent BioSolutions Inc. all-time high TTM EBITDA is $660.70M
What is Emergent BioSolutions Inc. TTM EBITDA year-on-year change?
Over the past year, EBS TTM EBITDA has changed by +$190.40M (+749.61%)